Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Mayo Clinic Proceedings
|
February 1, 1991
Essential thrombocythemia in young adults
K J McIntyre, H C Hoagland, M N Silverstein, et al.
Mayo Clinic Proceedings
|
June 1, 1991
Prognostic significance of computed tomography of the brain in thrombotic thrombocytopenic purpura
A C Kay, L A Solberg, D A Nichols, et al.
Annals of Internal Medicine
|
January 10, 1998
Hydroxyurea-induced leg ulceration in 14 patients
P J Best, M S Daoud, M R Pittelkow, et al.
Mayo Clinic Proceedings
|
March 1, 1991
Chromosome studies in 104 patients with polycythemia vera
J L Diez-Martin, D L Graham, R M Petitt, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1997
Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indications
A Tefferi, M N Silverstein, R M Petitt, et al.
Archives of Internal Medicine
|
June 12, 1995
Outcome analysis of 34 pregnancies in women with essential thrombocythemia
A H Beressi, A Tefferi, M N Silverstein, et al.
Annals of Internal Medicine
|
September 1, 1981
Vinblastine-loaded platelets for autoimmune hemolytic anemia
M A Gertz, R M Petitt, A A Pineda, et al.
Journal of Clinical Apheresis
|
January 1, 1982
Treatment of thrombotic thrombocytopenic purpura with plasma exchange, antiplatelet agents, corticosteroid, and plasma infusion: Mayo Clinic experience
R L Breckenridge, L A Solberg, A A Pineda, et al.
The New England Journal of Medicine
|
May 19, 1988
Anagrelide: a new drug for treating thrombocytosis
M N Silverstein, R M Petitt, L A Solberg, et al.
British Journal of Haematology
|
November 14, 1997
The effects of anagrelide on human megakaryocytopoiesis
L A Solberg, A Tefferi, K J Oles, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Mayo Clinic Proceedings
|
February 1, 1991
Essential thrombocythemia in young adults
K J McIntyre, H C Hoagland, M N Silverstein, et al.
Mayo Clinic Proceedings
|
June 1, 1991
Prognostic significance of computed tomography of the brain in thrombotic thrombocytopenic purpura
A C Kay, L A Solberg, D A Nichols, et al.
Annals of Internal Medicine
|
January 10, 1998
Hydroxyurea-induced leg ulceration in 14 patients
P J Best, M S Daoud, M R Pittelkow, et al.
Mayo Clinic Proceedings
|
March 1, 1991
Chromosome studies in 104 patients with polycythemia vera
J L Diez-Martin, D L Graham, R M Petitt, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1997
Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indications
A Tefferi, M N Silverstein, R M Petitt, et al.
Archives of Internal Medicine
|
June 12, 1995
Outcome analysis of 34 pregnancies in women with essential thrombocythemia
A H Beressi, A Tefferi, M N Silverstein, et al.
Annals of Internal Medicine
|
September 1, 1981
Vinblastine-loaded platelets for autoimmune hemolytic anemia
M A Gertz, R M Petitt, A A Pineda, et al.
Journal of Clinical Apheresis
|
January 1, 1982
Treatment of thrombotic thrombocytopenic purpura with plasma exchange, antiplatelet agents, corticosteroid, and plasma infusion: Mayo Clinic experience
R L Breckenridge, L A Solberg, A A Pineda, et al.
The New England Journal of Medicine
|
May 19, 1988
Anagrelide: a new drug for treating thrombocytosis
M N Silverstein, R M Petitt, L A Solberg, et al.
British Journal of Haematology
|
November 14, 1997
The effects of anagrelide on human megakaryocytopoiesis
L A Solberg, A Tefferi, K J Oles, et al.
Page
of 3